Advanced chordoma treated by first-line molecular targeted therapies: Outcomes and prognostic factors. A retrospective study of the French Sarcoma Group (GSF/GETO) and the Association des Neuro-Oncologues d'Expression Française (ANOCEF).-论文-万方医学网

第一作者： Loïc,Lebellec

第一单位： Department of General Oncology, Centre Oscar Lambret, Lille, France.

作者： Loïc,Lebellec ^[1] ; Bruno,Chauffert ^[2] ; Jean-Yves,Blay ^[3] ; Axel,Le Cesne ^[4] ; Christine,Chevreau ^[5] ; Emmanuelle,Bompas ^[6] ; François,Bertucci ^[7] ; Didier,Cupissol ^[8] ; Michel,Fabbro ^[8] ; Esma,Saada-Bouzid ^[9] ; Florence,Duffaud ^[10] ; Loïc,Feuvret ^[11] ; Alice,Bonneville-Levard ^[3] ; Jacques-Olivier,Bay ^[12] ; Elodie,Vauleon ^[13] ; Armelle,Vinceneux ^[14] ; Georges,Noel ^[15] ; Nicolas,Penel ^[16] ; Olivier,Mir ^[4]

作者单位： Department of General Oncology, Centre Oscar Lambret, Lille, France. ^[1] Department of Medical Oncology, University Hospital (CHU), Amiens, France. ^[2] Department of Medical Oncology, Centre Léon Bérard, Lyon, France. ^[3] Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. ^[4] Department of Medical Oncology, Institut Claudius Regaud, Toulouse, France. ^[5] Department of Medical Oncology, Centre René Gauducheau, Nantes, France. ^[6] Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France. ^[7] Department of Medical Oncology, Institut regional du cancer, Montpellier, France. ^[8] Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France. ^[9] Department of Medical Oncology, University Hospital La Timone (CHU), Marseille, France. ^[10] Department of Radiotherapy, University Hospital La Pitié-Salpétrière (CHU) (APHP), Paris, France. ^[11] Cellular Therapy and Clinic Hematology Unit for Adults, University Hospital (CHU), Clermont-Ferrand, France. ^[12] Department of Medical Oncology, Eugène Marquis Cancer Institute, Rennes, France. ^[13] Department of Medical Oncology, University Hospital (CHU) Bretonneau, Tours, France. ^[14] Department of Radiotherapy, Centre Paul Strauss, Strasbourg, France. ^[15] Department of General Oncology, Centre Oscar Lambret, Lille, France; Clinical Research and Methodology Platform, SIRIC OncoLille Consortium, Lille, France. Electronic address: n-penel@o-lambret.fr. ^[16]

主题词青少年(Adolescent);成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤药(Antineoplastic Agents);儿童(Child);脊索瘤(Chordoma);女(雌)性(Female);法国(France);人类(Humans);吲哚类(Indoles);男(雄)性(Male);中年人(Middle Aged);分子靶向治疗(Molecular Targeted Therapy);烟酰胺(Niacinamide);苯脲化合物(Phenylurea Compounds);吡咯类(Pyrroles);回顾性研究(Retrospective Studies);西罗莫司(Sirolimus);颅底肿瘤(Skull Base Neoplasms);治疗结果(Treatment Outcome);青年人(Young Adult)

DOI 10.1016/j.ejca.2017.03.037

PMID 28478340

发布时间 2022-03-31

检索历史清除

Advanced chordoma treated by first-line molecular targeted therapies: Outcomes and prognostic factors. A retrospective study of the French Sarcoma Group (GSF/GETO) and the Association des Neuro-Oncologues d'Expression Française (ANOCEF).

European journal of cancer (Oxford, England

相似文献

European journal of cancer (Oxford, England

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Advanced chordoma treated by first-line molecular targeted therapies: Outcomes and prognostic factors. A retrospective study of the French Sarcoma Group (GSF/GETO) and the Association des Neuro-Oncologues d'Expression Française (ANOCEF).

European journal of cancer (Oxford, England

相似文献

European journal of cancer (Oxford, England

相关期刊

检索历史清除